申请人:Jacobus Pharmaceutical Co., Inc.
公开号:US20030144361A1
公开(公告)日:2003-07-31
Compounds of the formulae
1
a method of protecting subjects from infections caused by an organism of the group: Plasmodium sp. Mycobacterium sp.,
P. falciparum, M. avium
complex,
M. tuberculosis, M. Kanasii
and
Pneumocystis carinii
by administering to the subjects liable to infections, a prophylactically effective amount of a compound of the foregoing formulae; and a method of reducing the level of infection in subjects caused by the above-listed organism by administering to the subjects an infection reductively effective amount of a compound of the foregoing formulae.
化合物的公式1a,用于保护受试者免受以下组织的感染:疟原虫、结核分枝杆菌、恶性疟原虫、埃美柯杆菌复合体、结核分枝杆菌、卡那西杆菌和肺孢子菌。通过向易感染感染的受试者投予上述公式的预防有效量,可以保护受试者免受感染;并且通过向受试者投予上述公式的感染还原有效量,可以降低由上述组织引起的感染水平。